Liver Disease and Intermediate α1‐Antitrypsin Deficiency
Open Access
- 12 January 1981
- journal article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 210 (1-6) , 241-244
- https://doi.org/10.1111/j.0954-6820.1981.tb09809.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intra- and extracellular alpha 1-antitrypsin in liver disease with special reference to Pi phenotype.Journal of Clinical Pathology, 1981
- Heterozygous MZ Alpha1-Antitrypsin Deficiency in Adults with Chronic Active Hepatitis and Cryptogenic CirrhosisNew England Journal of Medicine, 1981
- Danazol-induced Augmentation of Serum α1-Antitrypsin Levels in Individuals with Marked Deficiency of this AntiproteaseJournal of Clinical Investigation, 1980
- α1‐Antitrypsin and other Acute Phase Reactants in Liver DiseaseActa Medica Scandinavica, 1980
- Natural History and Life Expectancy in Severe Alpha1‐Antitrypsin Deficiency, Pi ZActa Medica Scandinavica, 1978
- Proteases and Protease Inhibitors in Chronic Obstructive Lung DiseaseActa Medica Scandinavica, 1978
- α-1 Antitrypsin phenotypes determined by isoelectric focusing of the cysteine-antitrypsin mixed disulfide in serumAnalytical Biochemistry, 1976
- HETEROZYGOUS ALPHA1-ANTITRYPSIN DEFICIENCY AND CIRRHOSIS IN ADULTS, A FORTUITOUS ASSOCIATIONThe Lancet, 1975
- Liver, Lung and Malignant Disease in Heterozygous (Pi MZ) α1‐antitrypsin DeficiencyActa Medica Scandinavica, 1975
- CIRRHOSIS AND MALIGNANT HEPATOMA IN α1‐ANTITRYPSIN DEFICIENCYActa Medica Scandinavica, 1974